Standardization of açaí extracts for in-vitro assays based on anthocyanin quantitation
- PMID: 36844472
- PMCID: PMC9957365
- DOI: 10.1016/j.jfca.2023.105155
Standardization of açaí extracts for in-vitro assays based on anthocyanin quantitation
Abstract
Euterpe oleracea Mart., commonly known as açaí, is a fruit that grows on a palm tree native to the Amazon region. Quantitation of bioactive constituents is a crucial preliminary step before utilizing extracts for biological assays so they may be normalized and administered according to a specific constituent concentration. Açaí has four main anthocyanin analytes: cyanidin 3-glucoside, cyanidin 3-sambubioside, cyanidin 3-rutinoside, and peonidin 3-rutinoside. This is the first comparison of açaí anthocyanin profiles between fresh fruits, processed powders, and botanical dietary supplement capsules. The materials examined shared a similar anthocyanin profile, with cyanidin 3-rutinoside being the most abundant (0.380 ± 0.006 - 15.1 ± 0.01 mg/g), followed by cyanidin 3-glucoside (0.0988 ± 0.0031 - 8.95 ± 0.01 mg/g). Among the botanical dietary supplement capsules, the two formulations varied greatly in anthocyanin concentration despite both being aqueous extracts (0.650 ± 0.011 - 0.924 ± 0.010 mg/g versus 1.23 ± 0.01 - 1.27 ± 0.02 mg/g). Previous LC-MS methods range from 35-120 min per injection, while we report a 10 min quantitative method for analysis of anthocyanins in various açaí materials that is fast, reproducible, and accurate. The method produced is useful to assure the quality, efficacy and safety of food and dietary supplement materials containing açaí.
Keywords: Arecaceae; Euterpe oleracea Mart; cyanidin 3-glucoside; cyanidin 3-rutinoside; cyanidin 3-sambubioside; mass spectrometry; peonidin 3-rutinoside.
Conflict of interest statement
Conflicts of Interest The authors declare no conflicts of interest.
Figures




References
-
- Bijauliya RKK, Alok S, Chanchal DK, & Kumar M (2017). A comprehensive review on standardization of herbal drugs. Int. J. Pharm. Sci. Res, 8, 3663–3677
-
- Carvalho AV, Ferreira Ferreira da Silveira T, Mattietto R. d. A., Padilha de Oliveira M. d. S., & Godoy HT (2017). Chemical composition and antioxidant capacity of açaí (Euterpe oleracea) genotypes and commercial pulps. Journal of the Science of Food and Agriculture, 97(5), 1467–1474. doi:10.1002/jsfa.7886 - DOI - PubMed
-
- Fahim SM, Mishuk AU, Cheng N, Hansen R, Calderón AI, & Qian J (2019). Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS). Expert Opinion on Drug Safety, 18(2), 145–152. doi:10.1080/14740338.2019.1562546 - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources